There are 3397 resources available
1318MO - First-in-human study of ABBV-637, an EGFR-targeting BCL-XL–inhibiting antibody-drug conjugate combined with osimertinib (OSI) in relapsed/refractory, EGFR-mutated non-small cell lung cancer (NSCLC)
Presenter: Julia Rotow
Session: Mini oral session 2 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
LBA100 - CUP-ONE trial: A prospective double-blind validation of molecular classifiers in the diagnosis of cancer of unknown primary and clinical outcomes
Presenter: Harpreet Wasan
Session: Mini oral session - Basic science & translational research
Resources:
Abstract
Slides
Webcast
LBA53 - Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET)
Presenter: Jennifer Chan
Session: Proffered Paper session - NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast
380MO - SKB264 (MK-2870) in previously treated hormone receptor-positive (HR+)/ HER2-negative metastatic breast cancer (mBC): Results from a phase I/II, single-arm, basket trial
Presenter: yongmei yin
Session: Mini oral session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
653O - Glecirasib (KRAS G12C inhibitor) in combination with JAB-3312 (SHP2 inhibitor) in patients with KRAS p.G12C mutated solid tumors
Presenter: Jie Wang
Session: Proffered Paper session - Developmental therapeutics
Resources:
Abstract
Slides
Webcast
1767MO - External validation of a digital pathology-based multimodal artificial intelligence (MMAI)-derived model in high-risk localized (M0)/metastatic (M1) prostate cancer (PCa) starting androgen deprivation therapy (ADT) in the docetaxel (Doc) or abiraterone (AAP) phase III STAMPEDE trials
Presenter: Charles Parker
Session: Mini oral session - Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
Invited Discussant 1913O
Presenter: Dario Callegaro
Session: Proffered Paper session - Sarcoma
Resources:
Slides
Webcast
Perioperative immunotherapy for head and neck squamous cell carcinoma (HNSCC)
Presenter: Athanassios Argiris
Session: Immunotherapy for head and neck cancer: What, when and how long?
Resources:
Slides
Webcast
ctDNA assessment: How and when?
Presenter: Klaus Pantel
Session: Circulating tumour DNA: A perfect fit?
Resources:
Slides
Webcast
Practical tips from a former fellow
Presenter: Alexios Matikas
Session: YO Fellowship Session: Fellowships in Europe: Educational opportunities for young oncologists
Resources:
Slides
Webcast